Drug Pipeline

Tozorakimab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT06932263
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With…		 Trial sites expanded: 209 -> 213 locations
Active Studies by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06040086 Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease… Chronic Obstructive Pulmonary Disease (COPD) Active, Not Recruiting
Phase 2
NCT06932263 Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With… Asthma Recruiting
NCT06897748 A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With… Chronic Obstructive Pulmonary Disease (COPD) Active, Not Recruiting
Sponsors Running Tozorakimab Trials
AstraZeneca (3)
Disease Areas
COPD (2) Asthma (1)
Get alerts when Tozorakimab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free